V
56
8
AEE
50
7
ZION
40
-4
TEL
57
2
UHS
46
2
CAH
37
3
CTAS
28
-14
SBUX
31
2
OI
20
-3
LMT
34
14
TDC
67
2
LUV
42
3
XRX
46
2
SE
57
2
SO
42
3
MAT
39
-2
EFX
40
2
TJX
47
-4
KLAC
42
-8
SYK
46
2
V
56
8
AEE
50
7
ZION
40
-4
TEL
57
2
UHS
46
2
CAH
37
3
CTAS
28
-14
SBUX
31
2
OI
20
-3
LMT
34
14
TDC
67
2
LUV
42
3
XRX
46
2
SE
57
2
SO
42
3
MAT
39
-2
EFX
40
2
TJX
47
-4
KLAC
42
-8
SYK
46
2
Financhill
Back

ProPhase Labs Quote, Financials, Valuation and Earnings

The AI Energy Miracle

Details Here.
Sell
11

PRPH
ProPhase Labs

Last Price:
$0.65
Seasonality Move:
4.58%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

ProPhase Labs Price Quote

$0.65
0.00 (-9.09%)
(Updated: December 20, 2024 at 5:31 AM ET)

ProPhase Labs Key Stats

Sell
11
ProPhase Labs (PRPH) is a Sell
Day range:
$0.65 - $0.72
52-week range:
$0.64 - $7.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.95
P/B ratio:
0.41%
Volume:
84.8K
Avg. volume:
331.2K
1-year change:
-85.49%
Market cap:
$15.6M
Revenue:
$44.4M
EPS:
$-1.54

How Much Does ProPhase Labs Make?

Data Unavailable

Is ProPhase Labs Growing As A Company?

Data Unavailable

ProPhase Labs Stock Price Performance

  • Did ProPhase Labs Stock Go Up Last Month?
    ProPhase Labs share price went down by -14.07% last month
  • Did PRPH's Share Price Rise Over The Last Year?
    PRPH share price fell by -85.49% over the past 1 year

What Is ProPhase Labs 52-Week High & Low?

ProPhase Labs Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ProPhase Labs?

Data Unavailable

Is ProPhase Labs Cash Flow Positive?

Data Unavailable

ProPhase Labs Return On Invested Capital

Data Unavailable

ProPhase Labs Earnings Date & Stock Price

ProPhase Labs Competitors

  • Who Are ProPhase Labs's Competitors?
    Below is a list of companies who compete with ProPhase Labs or are related in some way:
    • Applied DNA Sciences Inc (APDN)
    • Fonar Corp (FONR)
    • OncoCyte Corp (OCX)
    • Veracyte Inc (VCYT)
    • XWELL Inc (XWEL)

ProPhase Labs Dividend Yield

Data Unavailable

ProPhase Labs Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.9%
Revenue: -62.39% 11.56%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable